微质中的糖溶性重编程:对于缺血性中风的潜在治疗点
Guangming Zhang1, Anliu Zhao1, Xiaolu Zhang1
1School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Cellular signalling
|October 17, 2024
概括
微质细胞,大脑的免疫细胞,在缺血性中风期间切换它们的能量来源. 了解这种代谢转变可能会揭示中风治疗的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
背景情况:
- 缺血性中风是全球主要的死亡原因,治疗方法有限.
- 微质细胞是大脑中的关键免疫细胞,对缺血性损伤做出反应.
- 微质代谢重编程,从氧化酸化转变为糖解,与中风病理学有关.
研究的目的:
- 研究微质代谢重编程在缺血性中风中的作用.
- 阐明驱动这种代谢转变的调节机制.
- 为了确定潜在的治疗点或中风的候选药物.
主要方法:
- 这项研究可能将涉及缺血性中风的体外和体内模型.
- 技术可能包括代谢分析,基因表达分析和细胞成像.
- 重点将是分析微质代谢途径及其功能后果.
主要成果:
- 初步发现表明,微质新陈代谢发生了显著的转变,转向血糖溶解后缺血.
- 这种代谢重编程会影响炎症反应和神经元的存活.
- 正在确定管理这种转变的具体监管途径.
结论:
- 微质代谢重编程是缺血性中风的一个关键因素.
- 针对这种代谢途径提供了一个有前途的治疗策略.
- 进一步的研究旨在开发用于中风治疗的调节微质代谢的药物.
更多相关视频
11:36A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia
Published on: November 14, 2020
9.3K
05:40AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
Published on: November 29, 2024
406
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hypoglycemia
30
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
